
Approximately 300 million people worldwide are living with a rare disease, and due to the limited patient population, clinical trials for these conditions present unique considerations, particularly around recruitment and retention. Cross-border patient participation, allowing for a broader patient pool, is a necessity. This approach can lead to additional complexities if not well-considered in advance and/or without practical experience. Key considerations include site selection, patient transportation, language and cultural barriers, differing legislation between countries, managing patient care, and patient education – each of which is critical for the success of rare disease clinical trials.
In this webinar, Medpace, a global full-service CRO, will explore strategies for cross-border patient participation, drawing on lessons learned from years of experience running these trials. Medpace rare disease experts will share key cross-border enrollment and retention factors for conducting these trials, covering regulatory intelligence, operational considerations, and methods for enhancing patient experience.
Register now for the upcoming webinar on Rare Disease Day 2025 to join Medpace experts as they share insights and strategies for success without boundaries.
Innovative Patient Enrollment and Retention Approaches for Rare Disease Clinical Trials
Rare disease trials demand a highly experienced, full-service CRO with innovative strategies to identify and engage sites and scarce patient populations, with expertise in site and project management to achieve study aims. Drive patient recruitment and site selection for difficult-to-recruit studies with guidance from our experienced team of cross-functional, rare disease experts, innovative study approaches, and strong site relationships.